{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T13:25:21Z","timestamp":1791033921580,"version":"4.1.0"},"reference-count":27,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.3892\/or.2013.2334","type":"journal-article","created":{"date-parts":[[2013,3,6]],"date-time":"2013-03-06T09:48:29Z","timestamp":1362563309000},"page":"2072-2078","source":"Crossref","is-referenced-by-count":20,"title":["Indirubin-3\u2032-monoxime promotes autophagic and apoptotic death in JM1 human acute lymphoblastic leukemia cells and K562 human chronic myelogenous leukemia cells"],"prefix":"10.3892","volume":"29","author":[{"given":"MING-YANG","family":"LEE","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YI-WEN","family":"LIU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MING-HO","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JIN-YI","family":"WU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HSING-YING","family":"HO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"QWA-FUN","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JING-JING","family":"CHUANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2013,3,6]]},"reference":[{"key":"key20180107214208_b1-or-29-05-2072","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra052603","article-title":"Treatment of acute lymphoblastic leukemia","volume":"354","author":"Pui","year":"2006","journal-title":"N Engl J Med"},{"key":"key20180107214208_b2-or-29-05-2072","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1182\/blood-2006-05-018192","article-title":"Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12\/ECOG 2993 study","volume":"109","author":"Fielding","year":"2007","journal-title":"Blood"},{"key":"key20180107214208_b3-or-29-05-2072","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1038\/sj.leu.2404824","article-title":"Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial","volume":"21","author":"Tavernier","year":"2007","journal-title":"Leukemia"},{"key":"key20180107214208_b4-or-29-05-2072","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/9035","article-title":"Indirubin, the active constituent of a Chinese antileukemia medicine, inhibits cyclin-dependent kinases","volume":"1","author":"Hoessel","year":"1999","journal-title":"Nat Cell Biol"},{"key":"key20180107214208_b5-or-29-05-2072","first-page":"83","article-title":"Experimental and clinical studies of indirubin in the treatment of CML","volume":"18","year":"1979","journal-title":"Chinese J Intern Med"},{"key":"key20180107214208_b6-or-29-05-2072","first-page":"132","article-title":"Clinical studies of 314 cases of CML treated with indirubin","volume":"1","year":"1980","journal-title":"Chinese J Intern Med"},{"key":"key20180107214208_b7-or-29-05-2072","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1054\/bjoc.2000.1546","article-title":"Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells","volume":"84","author":"Marko","year":"2001","journal-title":"Br J Cancer"},{"key":"key20180107214208_b8-or-29-05-2072","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/cbic.200400108","article-title":"From the insoluble dye indirubin towards highly active, soluble CDK2-inhibitors","volume":"6","author":"Jautelat","year":"2005","journal-title":"Chembiochem"},{"key":"key20180107214208_b9-or-29-05-2072","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.canlet.2008.08.033","article-title":"5\u2032-nitro-indirubinoxime induces G2\/M cell cycle arrest and apoptosis in human KB oral carcinoma cells","volume":"274","author":"Kim","year":"2009","journal-title":"Cancer Lett"},{"key":"key20180107214208_b10-or-29-05-2072","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.bbagen.2009.11.007","article-title":"5\u2032-Nitro-indirubinoxime induces G1 cell cycle arrest and apoptosis in salivary gland adenocarcinoma cells through the inhibition of Notch-1 signaling","volume":"1800","author":"Yoon","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"key20180107214208_b11-or-29-05-2072","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejphar.2011.07.047","article-title":"A novel indirubin derivative PHII-7 potentiates adriamycin cytotoxicity via inhibiting P-glycoprotein expression in human breast cancer MCF-7\/ADR cells","volume":"669","author":"Shi","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"key20180107214208_b12-or-29-05-2072","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/cmdc.200900506","article-title":"Synthesis of thia-analogous indirubin N-Glycosides and their influence on melanoma cell growth and apoptosis","volume":"5","author":"Kunz","year":"2010","journal-title":"ChemMedChem"},{"key":"key20180107214208_b13-or-29-05-2072","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bcp.2010.09.010","article-title":"Sensitization of melanoma cells for death ligand-induced apoptosis by an indirubin derivative. Enhancement of both extrinsic and intrinsic apoptosis pathways","volume":"81","author":"Berger","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"key20180107214208_b14-or-29-05-2072","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.biopha.2008.03.005","article-title":"Indirubin-3-monooxime induced cell cycle arrest and apoptosis in Hep-2 human laryngeal carcinoma cells","volume":"63","author":"Kameswaran","year":"2009","journal-title":"Biomed Pharmacother"},{"key":"key20180107214208_b15-or-29-05-2072","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1365-2141.2005.05655.x","article-title":"Indirubin, a Chinese anti-leukaemia drug, promotes neutrophilic differentiation of human myelocytic leukemia HL-60 cells","volume":"130","author":"Suzuki","year":"2005","journal-title":"Br J Haematol"},{"key":"key20180107214208_b16-or-29-05-2072","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nrc1412","article-title":"Pathways of apoptotic and non-apoptotic death in tumour cells","volume":"4","author":"Okada","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"key20180107214208_b17-or-29-05-2072","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.1038\/sj.onc.1209648","article-title":"7-Bromoindirubin-3\u2032-oxime induces caspase-independent cell death","volume":"25","author":"Ribas","year":"2006","journal-title":"Oncogene"},{"key":"key20180107214208_b18-or-29-05-2072","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bcp.2008.03.023","article-title":"7-Bromoindirubin-3\u2032-oxime uncovers a serine protease-mediated paradigm of necrotic cell death","volume":"76","author":"Ribas","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"key20180107214208_b19-or-29-05-2072","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nrc1692","article-title":"The role of autophagy in cancer development and response to therapy","volume":"5","author":"Kondo","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"key20180107214208_b20-or-29-05-2072","first-page":"461","article-title":"LC3, an autophagosome marker, is highly expressed in gastrointestinal cancers","volume":"33","author":"Yoshioka","year":"2008","journal-title":"Int J Oncol"},{"key":"key20180107214208_b21-or-29-05-2072","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1093\/emboj\/19.21.5720","article-title":"LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing","volume":"19","author":"Kabeya","year":"2000","journal-title":"EMBO J"},{"key":"key20180107214208_b22-or-29-05-2072","doi-asserted-by":"crossref","first-page":"947","DOI":"10.4161\/auto.6787","article-title":"Beclin 1 bridges autophagy, apoptosis and differentiation","volume":"4","author":"Wang","year":"2008","journal-title":"Autophagy"},{"key":"key20180107214208_b23-or-29-05-2072","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2353\/ajpath.2007.060524","article-title":"Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death","volume":"170","author":"Zhu","year":"2007","journal-title":"Am J Pathol"},{"key":"key20180107214208_b24-or-29-05-2072","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.abb.2007.03.034","article-title":"Selective degradation of mitochondria by mitophagy","volume":"462","author":"Kim","year":"2007","journal-title":"Arch Biochem Biophys"},{"key":"key20180107214208_b25-or-29-05-2072","doi-asserted-by":"crossref","first-page":"29900","DOI":"10.1074\/jbc.M003633200","article-title":"Leucine limitation induces autophagy and activation of lysosome-dependent proteolysis in C2C12 myotubes through a mammalian target of rapamycin-dependent signaling pathway","volume":"275","author":"Mordier","year":"2000","journal-title":"J Biol Chem"},{"key":"key20180107214208_b26-or-29-05-2072","doi-asserted-by":"crossref","first-page":"8452","DOI":"10.1074\/jbc.M306337200","article-title":"Amino acids and insulin control autophagic proteolysis through different signaling pathways in relation to mTOR in isolated rat hepatocytes","volume":"279","author":"Kanazawa","year":"2004","journal-title":"J Biol Chem"},{"key":"key20180107214208_b27-or-29-05-2072","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/10428190601059696","article-title":"Inhibition of normal lymphocyte proliferation by indirubin-3\u2032-monoxime: a multifactorial process","volume":"48","author":"Kagialis-Girard","year":"2007","journal-title":"Leuk Lymphoma"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2013.2334\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T21:42:28Z","timestamp":1515361348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2013.2334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,6]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,3,6]]},"published-print":{"date-parts":[[2013,5]]}},"alternative-id":["10.3892\/or.2013.2334"],"URL":"https:\/\/doi.org\/10.3892\/or.2013.2334","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,6]]}}}